TDMS Study 92012-04 Pathology Tables
NTP Experiment-Test: 92012-04 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02 Study Type: SUBCHRON 90-DAY 2-METHYLIMIDAZOLE Date: 08/06/96 Route: DOSED FEED Time: 20:29:51 90-DAY Facility: Microbiological Associates Chemical CAS #: 693-98-1 Lock Date: 08/31/94 Cage Range: All Reasons For Removal: All Removal Date Range: All Treatment Groups: Include All a Number of animals examined microscopically at site and number of animals with lesion Page 1 NTP Experiment-Test: 92012-04 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02 Study Type: SUBCHRON 90-DAY 2-METHYLIMIDAZOLE Date: 08/06/96 Route: DOSED FEED Time: 20:29:51 ____________________________________________________________________________________________________________________________________ B6C3F1 MICE FEMALE UNTREAT 625 1250 2500 5000 10000 CONTROL PPM PPM PPM PPM PPM ____________________________________________________________________________________________________________________________________ DISPOSITION SUMMARY Animals Initially in Study 10 10 10 10 10 10 Early Deaths Survivors Terminal Sacrifice 10 10 9 10 10 8 Accidently Killed 1 2 Animals Examined Microscopically 10 10 10 10 10 10 ____________________________________________________________________________________________________________________________________ ALIMENTARY SYSTEM None ____________________________________________________________________________________________________________________________________ CARDIOVASCULAR SYSTEM None ____________________________________________________________________________________________________________________________________ ENDOCRINE SYSTEM None ____________________________________________________________________________________________________________________________________ GENERAL BODY SYSTEM None ____________________________________________________________________________________________________________________________________ GENITAL SYSTEM None ____________________________________________________________________________________________________________________________________ HEMATOPOIETIC SYSTEM None ____________________________________________________________________________________________________________________________________ INTEGUMENTARY SYSTEM None ____________________________________________________________________________________________________________________________________ Page 2 NTP Experiment-Test: 92012-04 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02 Study Type: SUBCHRON 90-DAY 2-METHYLIMIDAZOLE Date: 08/06/96 Route: DOSED FEED Time: 20:29:51 ____________________________________________________________________________________________________________________________________ B6C3F1 MICE FEMALE UNTREAT 625 1250 2500 5000 10000 CONTROL PPM PPM PPM PPM PPM ____________________________________________________________________________________________________________________________________ MUSCULOSKELETAL SYSTEM None ____________________________________________________________________________________________________________________________________ NERVOUS SYSTEM None ____________________________________________________________________________________________________________________________________ RESPIRATORY SYSTEM None ____________________________________________________________________________________________________________________________________ SPECIAL SENSES SYSTEM None ____________________________________________________________________________________________________________________________________ URINARY SYSTEM None Page 3 NTP Experiment-Test: 92012-04 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02 Study Type: SUBCHRON 90-DAY 2-METHYLIMIDAZOLE Date: 08/06/96 Route: DOSED FEED Time: 20:29:51 ____________________________________________________________________________________________________________________________________ B6C3F1 MICE MALE UNTREAT 625 1250 2500 5000 10000 CONTROL PPM PPM PPM PPM PPM ____________________________________________________________________________________________________________________________________ DISPOSITION SUMMARY Animals Initially in Study 10 10 10 10 10 10 Early Deaths Survivors Terminal Sacrifice 10 9 9 10 10 9 Accidently Killed 1 1 1 Animals Examined Microscopically 10 10 10 10 10 10 ____________________________________________________________________________________________________________________________________ ALIMENTARY SYSTEM None ____________________________________________________________________________________________________________________________________ CARDIOVASCULAR SYSTEM None ____________________________________________________________________________________________________________________________________ ENDOCRINE SYSTEM None ____________________________________________________________________________________________________________________________________ GENERAL BODY SYSTEM None ____________________________________________________________________________________________________________________________________ GENITAL SYSTEM None ____________________________________________________________________________________________________________________________________ HEMATOPOIETIC SYSTEM None ____________________________________________________________________________________________________________________________________ INTEGUMENTARY SYSTEM None ____________________________________________________________________________________________________________________________________ Page 4 NTP Experiment-Test: 92012-04 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02 Study Type: SUBCHRON 90-DAY 2-METHYLIMIDAZOLE Date: 08/06/96 Route: DOSED FEED Time: 20:29:51 ____________________________________________________________________________________________________________________________________ B6C3F1 MICE MALE UNTREAT 625 1250 2500 5000 10000 CONTROL PPM PPM PPM PPM PPM ____________________________________________________________________________________________________________________________________ MUSCULOSKELETAL SYSTEM None ____________________________________________________________________________________________________________________________________ NERVOUS SYSTEM None ____________________________________________________________________________________________________________________________________ RESPIRATORY SYSTEM None ____________________________________________________________________________________________________________________________________ SPECIAL SENSES SYSTEM None ____________________________________________________________________________________________________________________________________ URINARY SYSTEM None Page 5 ------------------------------------------------------------ ---------- END OF REPORT ---------- ------------------------------------------------------------